1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Cancer Drug News 07 SEPTEMBER 2015

Cancer Drug News 07 SEPTEMBER 2015

  • September 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - ADCs Returning To Forefront Of Oncology Drug Development
Industry Brief - FDA Accepts Empliciti For Priority Review
Industry Brief - FDA Accepts sBLA For Opdivo In Previously Treated Non-Squamous NSCLC
Industry Brief - MHLW Lifts All-Case Surveillance Condition For Eisai's Gliadel Implant
Industry Brief - Tafinlar+Mekinist Gains EU Approval For Advanced Melanoma
Industry Brief - NHS England Delists 16 Drugs From CDF
Industry Brief - FDA Grants Loxo Soft Tissue Sarcoma Drug ODD
Industry Trend Analysis - Incyte Faces Difficulty In Breaking Checkpoint Inhibitor Market
Industry Trend Analysis - Tesaro's First Drug Faces Battle For Position In Congested CINV Market
Industry Brief - FDA Approves Paediatric Indication For Emend
Industry Brief - Enrolment Completed In SGX942 Phase II Trial For Oral Mucositis In H&N Cancer
Industry Trend Analysis - BMS Aiming For Long-Term Immuno-oncology Dominance

Table Of Contents

Cancer Drug News 07 SEPTEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 10 125
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6 650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...


Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.